financetom
Business
financetom
/
Business
/
US regulator proposes extra scrutiny of bank mergers above $100 bln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US regulator proposes extra scrutiny of bank mergers above $100 bln
Mar 21, 2024 10:13 AM

March 21 (Reuters) - Mergers that could result in banks

with more than $100 billion in assets should expect heightened

scrutiny from the U.S. Federal Deposit Insurance Corporation,

according to a policy statement the top bank regulator proposed

on Thursday.

The FDIC's board of directors voted 3-2 to issue the

proposal, which would update the agency's merger guidance for

the first time in 16 years. The new guidance puts special

emphasis on maintaining the stability of the banking sector,

agency officials said in advance of the vote.

Bank mergers and industry consolidation have come under

intense scrutiny since last year, when three of the largest-ever

U.S. bank failures resulted in acquisitions and billions in

losses for the FDIC's insurance fund.

"The bank failures of 2023 underscore the risks that banks

with assets over $100 billion can have for financial stability,"

FDIC Chair Martin Gruenberg said at a public meeting ahead of

the vote.

Republican board members, however, opposed the proposal

saying it would make the process less predictable and entrench

what they called institutional bias against bank mergers.

Jonathan McKernan, a Republican member of the board, said

adding hurdles to mergers resulting in banks above $100 billion

could discourage the creation of new competitors to established

Wall Street giants.

"One of the potential unintended consequences...is that we

continue to enhance this moat of regulatory protection around

our largest banks," he said.

In a statement, the Bank Policy Institute, a major trade

group in Washington, said the new guidance continued "an

alarming trend" among regulators of discouraging bank mergers

and acquisitions and that its "subjective" standards would make

the merger review process more uncertain.

The draft proposal, which offers a statement of principles

rather than set procedures, says officials would also focus on

other financial stability concerns, such as whether a merged

bank would add complexity to the financial system and the extent

of its cross-border activities.

The changes reflect statutes adopted by Congress in 2010

under the Dodd-Frank Wall Street reform legislation, according

to the proposal, which is now subject to a 60-day period of

public comment.

Financial reform advocates such as Democratic Senator

Elizabeth Warren have expressed outrage that regulators allowed

Wall Street giant JPMorgan Chase & CO ( JPM ), already the

nation's largest bank, to acquire the failed First Republic Bank ( FRCB )

last year.

Despite misgivings about New York Community Bank's

exposure to commercial real estate and earlier concerns from

FDIC officials, the U.S. Office of the Comptroller of the

Currency, another banking regulator, in 2022 approved its merger

with Flagstar Bank of Michigan.

Regulators then approved NYCB's takeover of the failed

Signature Bank ( SBNY ) last year. The combined entity reported

a surprise loss in January and received a $1 billion capital

infusion this month a group of investors, including former U.S.

Treasury Secretary Steven Mnuchin.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal
Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal
Jan 21, 2025
09:15 AM EST, 01/21/2025 (MT Newswires) -- Keros Therapeutics ( KROS ) said Tuesday that it will receive a $200 million upfront payment from Takeda Pharmaceutical ( TAK ) in connection to a global development and commercialization license deal to advance elritercept. The license agreement with Takeda took effect on Jan. 16, the biopharmaceutical company said. Keros shares were up...
Exclusive-International Paper to win EU approval for $7.1 billion DS Smith deal
Exclusive-International Paper to win EU approval for $7.1 billion DS Smith deal
Jan 21, 2025
BRUSSELS (Reuters) -U.S.-based International Paper ( IP ) is set to get EU approval for its 5.8 billion pound ($7.12 billion) purchase of UK rival DS Smith ( DITHF ) after agreeing to sell assets to address competition concerns, people with direct knowledge of the matter said on Tuesday. The deal announced last April will boost International Paper's ( IP...
US energy mergers may slow in 2025 as deal sizes shrink, says Enverus
US energy mergers may slow in 2025 as deal sizes shrink, says Enverus
Jan 21, 2025
(Reuters) - The pace of U.S. upstream public-to-public mergers could slow in 2025 from their recent average of five per year along with a fall in deal sizes, according to a report from energy analytics firm Enverus that was released on Tuesday. The consolidation trend in the U.S. energy sector, which triggered deals amounting to $250 billion in 2023, stretched...
Tempus AI Stock Is Trading Higher Tuesday: What's Going On?
Tempus AI Stock Is Trading Higher Tuesday: What's Going On?
Jan 21, 2025
Tempus AI Inc ( TEM ) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company. What Happened: Pelosi disclosed in a new filing that she purchased 50 call options in Tempus AI ( TEM ) on Jan. 14 with a strike price of $20. The value of the calls is between $50,000...
Copyright 2023-2026 - www.financetom.com All Rights Reserved